HomePositive World NewsFirst Human Trial to Slash Bad Cholesterol by 50% With One Injection...

First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy

A one-time infusion of CRISPR gene editing therapy slashed dangerous cholesterol by 52%, with the patients still experiencing the benefit 12 months after initial treatment, and without side effects. The Cleveland Clinic in Ohio reported that their Phase 1 human trial showed a one-time infusion of a gene-editing therapy using…  | Written by Good News Network | Good News Network | Read full story at Read More


Discover more from Endless Glory Media

Subscribe to get the latest posts sent to your email.

Endless Glory Media
Endless Glory Mediahttp://www.endlessglorymedia.com
At the core of EndlessGlory Media is to create a digital space where Christians can connect to and grow on faith. We aim to build a vibrant community that fosters spiritual growth, encourages meaningful conversations, and provides a platform for uplifting content that aligns with Christian values.
RELATED ARTICLES

LEAVE A REPLY

- Advertisment -
Google search engine

Most Popular

Recent Comments